Home › Research › Mild cognitive impairment
Blood Neurofilament Light Chain and Phospho-Tau 181 in Subjects with Mild Cognitive Impairment Due to Age-Related Hearing Loss
Giuseppe Alberti, Daniele Portelli, Francesca Polito, Anita Maria Stella Graceffa, Laura Licitri, Sabrina Loteta, Margherita Maria Torre, Irene Gasparo et al.. Journal of Clinical Medicine, 2025-01-21
Topic: Brain proteins, microglia and lab models
Plain-language summary
Patients with hearing impairment presented slightly altered results on cognitive tests, typical of a mild cognitive impairment. At the same time, serum levels of neurofilament light chain and phospho-tau 181 were significantly increased compared to the matched control group. After the hearing aids fitting, auditory, cognitive, and serum values results improved. The results of the study highlight the cognitive involvement in patients with hearing impairment and identify neurofilament light chain and phospho-tau 181 as serum biomarkers of neurodegeneration useful in monitoring the pathology.
What this study adds
Evidence grade: Low
The record lists 30 participants. This study found that patients with hearing impairment and mild cognitive impairment had increased serum levels of neurofilament light chain and phospho-tau 181, and these values improved after hearing aid fitting. These biomarkers may be useful for monitoring, but no treatment or cure for Alzheimer's disease is tested.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Alberti, G., Portelli, D., Polito, F., Graceffa, A. M. S., Licitri, L., Loteta, S., et al. (2025). Blood Neurofilament Light Chain and Phospho-Tau 181 in Subjects with Mild Cognitive Impairment Due to Age-Related Hearing Loss. Journal of Clinical Medicine. https://doi.org/10.3390/jcm14030672
Vancouver
Alberti G, Portelli D, Polito F, Graceffa AMS, Licitri L, Loteta S, et al. Blood Neurofilament Light Chain and Phospho-Tau 181 in Subjects with Mild Cognitive Impairment Due to Age-Related Hearing Loss. Journal of Clinical Medicine. 2025. doi:10.3390/jcm14030672. PMID: 39941343.
BibTeX
@article{alberti2025-39941343,
author = {Alberti, Giuseppe and Portelli, Daniele and Polito, Francesca and Graceffa, Anita Maria Stella and Licitri, Laura and Loteta, Sabrina and Torre, Margherita Maria and Gasparo, Irene and others},
title = {{Blood Neurofilament Light Chain and Phospho-Tau 181 in Subjects with Mild Cognitive Impairment Due to Age-Related Hearing Loss}},
journal = {Journal of Clinical Medicine},
year = {2025},
doi = {10.3390/jcm14030672},
pmid = {39941343},
url = {https://doi.org/10.3390/jcm14030672}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Patients with hearing impairment presented slightly altered results on cognitive tests, typical of a mild cognitive impairment.
- At the same time, serum levels of neurofilament light chain and phospho-tau 181 were significantly increased compared to the matched control group.
- After the hearing aids fitting, auditory, cognitive, and serum values results improved.
- The results of the study highlight the cognitive involvement in patients with hearing impairment and identify neurofilament light chain and phospho-tau 181 as serum biomarkers of neurodegeneration useful in monitoring the pathology.
Why it matters
This study found that patients with hearing impairment and mild cognitive impairment had increased serum levels of neurofilament light chain and phospho-tau 181, and these values improved after hearing aid fitting. These biomarkers may be useful for monitoring, but no treatment or cure for Alzheimer's disease is tested.
Study details
- Participants30
- Evidence strengthLow
How this study scored 40/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Clinical Medicine) |
| Journal's citation record | 2 / 4 | Journal of Clinical Medicine: journal h-index 188 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 30 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 7 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 4.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Vincenzo Macaione: h-index 15 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | University of Messina: institution h-index 447 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39941343) |
| Free to read | 2 / 2 | Free to read |
| Total | 40 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3390/jcm14030672
- PubMed: 39941343
- Original source →
- Free full text: Journal of Clinical Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 14.
Related studies in Mild cognitive impairment from nearby years
Also tagged “phosphorylated”
732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.